DK1373506T3 - Gærstamme af Saccaharomyces cerevisiae med funktionel ekspression af en Glut-transportör - Google Patents

Gærstamme af Saccaharomyces cerevisiae med funktionel ekspression af en Glut-transportör

Info

Publication number
DK1373506T3
DK1373506T3 DK02719792T DK02719792T DK1373506T3 DK 1373506 T3 DK1373506 T3 DK 1373506T3 DK 02719792 T DK02719792 T DK 02719792T DK 02719792 T DK02719792 T DK 02719792T DK 1373506 T3 DK1373506 T3 DK 1373506T3
Authority
DK
Denmark
Prior art keywords
yeast strain
functional expression
glut transporter
saccaharomyces
cerevisiae
Prior art date
Application number
DK02719792T
Other languages
English (en)
Inventor
Guenter Mueller
Klaus-Peter Koller
Eckhard Boles
Roman Wieczorke
Silke Dlugai
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1373506T3 publication Critical patent/DK1373506T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • C12N1/185Saccharomyces isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces
    • C12R2001/865Saccharomyces cerevisiae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK02719792T 2001-02-14 2002-02-09 Gærstamme af Saccaharomyces cerevisiae med funktionel ekspression af en Glut-transportör DK1373506T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106718A DE10106718A1 (de) 2001-02-14 2001-02-14 Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters
PCT/EP2002/001373 WO2002064784A2 (de) 2001-02-14 2002-02-09 Hefestamm von saccharomyces cerevisiae mit funktioneller expression eines glut-transporters

Publications (1)

Publication Number Publication Date
DK1373506T3 true DK1373506T3 (da) 2009-08-10

Family

ID=7673936

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02719792T DK1373506T3 (da) 2001-02-14 2002-02-09 Gærstamme af Saccaharomyces cerevisiae med funktionel ekspression af en Glut-transportör

Country Status (11)

Country Link
US (2) US7052900B2 (da)
EP (1) EP1373506B1 (da)
JP (2) JP4234995B2 (da)
AR (1) AR035228A1 (da)
AT (1) ATE428784T1 (da)
AU (1) AU2002250909A1 (da)
DE (2) DE10106718A1 (da)
DK (1) DK1373506T3 (da)
ES (1) ES2323855T3 (da)
TW (1) TWI374186B (da)
WO (1) WO2002064784A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10106718A1 (de) 2001-02-14 2002-09-05 Aventis Pharma Gmbh Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters
US7244821B2 (en) * 2002-09-14 2007-07-17 Sanofi-Aventis Deutschland Gmbh Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters
DE10242763A1 (de) * 2002-09-14 2004-03-18 Aventis Pharma Deutschland Gmbh Verwendung von Saccharomyces cerevisiae erg4-Mutanten zur Expression von Glukosetransportern aus Säugetieren
EP1661981A1 (en) * 2004-11-29 2006-05-31 Milan Prof. Dr. Höfer Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype
US11345908B2 (en) 2014-05-30 2022-05-31 Braskem S.A. Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same
WO2024002150A1 (en) * 2022-06-29 2024-01-04 Microbiota I - Center (Magic) Limited Methods and compositions for treating obesity using microorganisms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942398A (en) * 1998-02-26 1999-08-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding glutx and uses thereof
US7238531B2 (en) * 1999-01-30 2007-07-03 Pediatrix Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
WO2000075188A1 (en) 1999-06-09 2000-12-14 Whitehead Institute For Biomedical Research Method of measuring plasma membrane targeting of glut4
US20050147987A1 (en) * 2000-09-08 2005-07-07 Applera Corporation (Ny) Polymorphisms in known genes associated with type II diabetes and obesity, methods of detection and uses thereof
DE10106718A1 (de) 2001-02-14 2002-09-05 Aventis Pharma Gmbh Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters
US20040101848A1 (en) * 2002-11-23 2004-05-27 Isis Pharmaceuticals Inc. Modulation of glucose transporter-4 expression
US7244821B2 (en) 2002-09-14 2007-07-17 Sanofi-Aventis Deutschland Gmbh Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters

Also Published As

Publication number Publication date
EP1373506B1 (de) 2009-04-15
AR035228A1 (es) 2004-05-05
TWI374186B (en) 2012-10-11
TW200840867A (en) 2008-10-16
ATE428784T1 (de) 2009-05-15
AU2002250909A1 (en) 2002-08-28
US7052900B2 (en) 2006-05-30
DE50213446D1 (de) 2009-05-28
US20030166258A1 (en) 2003-09-04
ES2323855T3 (es) 2009-07-27
US8574909B2 (en) 2013-11-05
JP4234995B2 (ja) 2009-03-04
WO2002064784A3 (de) 2003-10-30
JP2004529622A (ja) 2004-09-30
US20060275319A1 (en) 2006-12-07
JP4287897B2 (ja) 2009-07-01
WO2002064784A2 (de) 2002-08-22
JP2008245656A (ja) 2008-10-16
EP1373506A2 (de) 2004-01-02
DE10106718A1 (de) 2002-09-05

Similar Documents

Publication Publication Date Title
CY2015050I2 (el) Βελτιστοποιημενη εκφραση της hpv 45 l1 σε ζυμη
CY2015051I1 (el) Βελτιστοποιημενη εκφραση hpv 58 l1 σε ζυμομυκητα
DE60335067D1 (de) Entspiegelungsschichten und ihre Herstellung
DE60328074D1 (de) Farbtonbereichsumsetzung unter Verwendung einer Kostenfunktion
DK1483526T3 (da) Flyveapparat med en flerhed af löfte- og skubberotorer
DE60336818D1 (de) Ausgangsregler
DE502004008445D1 (de) Energieautarker sensor
AU2003291975A1 (en) A toy building set with a vibraton sensor
AU2003213191A1 (en) Image sensor with interleaved image output
ITTO20020622A1 (it) Gruppo integrato puleggia-smorzatore torsionale
PT1484995E (pt) Guarda-chuva inclinavel
DK1485494T3 (da) Metabolsk manipulation til forbedret xyloseudnyttelse af saccharomyces cerevisiae
NO20025254D0 (no) Hjelpemiddel ved bruk av tamponger
ATE455555T1 (de) Glp-1-analoga
AU2003241276A1 (en) Analog-to-digital conversion
DK1373506T3 (da) Gærstamme af Saccaharomyces cerevisiae med funktionel ekspression af en Glut-transportör
AU2003287628A1 (en) High-speed analog-to-digital conversion with improved robustness to timing uncertainty
ATE382264T1 (de) Trockenhefe-komposition
DE60307239D1 (de) Artemisininderivate (endoperoxide) mit wirkung gegen parasiten
ITTO20020621A1 (it) Gruppo integrato puleggia-smorzatore torsionale
FI20030333A0 (fi) MSM-anturi
ATE552807T1 (de) Mit lotion versehener sekundärartikel
DE60324654D1 (de) Piezoelektrische Wandler
AU2003254485A1 (en) Wavelength-demultiplexer with integrated monolithic photodiodes
SE0102342D0 (sv) Modified yeast